TWiV 51: ALVAC-HIV and AIDSVAX B/E

September 27, 2009

thailandHosts: Vincent RacanielloDick Despommier, and Alan Dove

Vincent, Dick, and Alan (with a cameo appearance by Rich Condit) review the world’s largest Phase III study of a complex HIV vaccine candidate in Thailand, immunization of salmon against infectious salmon anemia virus, and an outbreak of blueberry shock virus in Michigan.

Click the arrow above to play, or right-click to download TWiV #51 (60 MB .mp3, 84 minutes)

Subscribe (free): iTunesRSSemail

Links for this episode:

Weekly Science Picks
Alan Bat Rabies and Other Lyssavirus Infections
Dick Boosting Vaccines: The Power of Adjuvants (Scientific American; subscription required)
Vincent The Ig Nobel Prizes by Marc Abrahams

Send your virology questions and comments to twiv@microbe.tv.

Leave a Reply

Your email address will not be published. Required fields are marked *

3 comments on “TWiV 51: ALVAC-HIV and AIDSVAX B/E

  1. chris Oct 2, 2009

    Hello from Vermont!

    I am taking a graduate biochemistry course while getting caught up with TWIV (new twiver) and TWIV is complementing my coursework nicely. I just had an exam on protein structure and the material links up with a lot of your topics. TWIV is informative, on target, funny, and even holds my polisci friend's attention.

    a very appreciative listener,
    Chris

    FYI — 2009 Podcast Awards
    Nominations Open Oct 4th 2009
    http://www.podcastawards.com/

  2. chris Oct 2, 2009

    Hello from Vermont!

    I am taking a graduate biochemistry course while getting caught up with TWIV (new twiver) and TWIV is complementing my coursework nicely. I just had an exam on protein structure and the material links up with a lot of your topics. TWIV is informative, on target, funny, and even holds my polisci friend's attention.

    a very appreciative listener,
    Chris

    FYI — 2009 Podcast Awards
    Nominations Open Oct 4th 2009
    http://www.podcastawards.com/

Content on this site is licensed by Microbe TV, LLC under a Creative Commons Attribution 3.0 License